NasdaqGS - Delayed Quote USD

QuidelOrtho Corporation (QDEL)

36.34
-0.12
(-0.33%)
At close: May 9 at 4:00:01 PM EDT
36.52
+0.18
+(0.50%)
After hours: May 9 at 7:49:28 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 692.8M
Earnings 50.2M

Q2'24

Q3'24

Q4'24

Q1'25

0
200M
400M
600M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

27.00 Low
47.14 Average
36.34 Current
60.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 7777
Avg. Estimate 0.030.732.373.22
Low Estimate -0.050.542.22.95
High Estimate 0.070.912.493.33
Year Ago EPS -0.070.851.852.37

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 8888
Avg. Estimate 613.31M691.24M2.71B2.82B
Low Estimate 604.56M648.06M2.7B2.79B
High Estimate 626.7M703.8M2.73B2.89B
Year Ago Sales 637M727.1M2.78B2.71B
Sales Growth (year/est) -3.72%-4.93%-2.66%4.23%

Earnings History

Currency in USD 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. -0.240.320.580.59
EPS Actual -0.070.850.630.74
Difference 0.170.530.050.15
Surprise % 70.64%168.53%8.54%25.03%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.030.732.373.22
7 Days Ago 0.110.742.343.25
30 Days Ago 0.110.742.363.3
60 Days Ago 0.130.712.383.27
90 Days Ago 0.210.632.433.33

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 1------
Up Last 30 Days 11--1
Down Last 7 Days --111
Down Last 30 Days 1132

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
QDEL 137.79%-14.63%28.07%35.97%
S&P 500 13.21%3.09%8.02%13.76%

Upgrades & Downgrades

Maintains UBS: Neutral to Neutral 5/8/2025
Upgrade Jefferies: Hold to Buy 5/8/2025
Maintains JP Morgan: Underweight to Underweight 4/21/2025
Maintains RBC Capital: Outperform to Outperform 2/13/2025
Maintains UBS: Neutral to Neutral 2/13/2025
Upgrade Citigroup: Neutral to Buy 12/11/2024

Related Tickers